PART 210
21 CFR Part 210 provides general CGMP requirements for manufacturing, processing, packing, and holding of drug products.
Usage Examples
- Program teams used PART 210 to align regulatory, quality, and clinical milestones.
- PART 210 improved consistency across global submission planning documents.
- PART 210 was included in the cross-functional regulatory decision log.
What is PART 210?
Part 210 works with Part 211 to define baseline manufacturing expectations for identity, strength, quality, and purity of drug products. Regulatory and quality teams use these requirements to structure facilities, procedures, investigations, and inspection readiness.
Regulatory Context
This term appears most often in general workflows where submission quality, regulatory evidence, and audit readiness depend on consistent language. It is commonly referenced alongside 21 CFR 210.
When This Matters
- Program teams used PART 210 to align regulatory, quality, and clinical milestones.
- PART 210 improved consistency across global submission planning documents.
- PART 210 was included in the cross-functional regulatory decision log.
Common Mistakes
- Relying on generic terminology without mapping to the active jurisdiction context.
- Skipping cross-links between terms, tools, and active regulatory references.
- Failing to maintain a single source of truth for regulatory definitions internally.
Related Regulations
Frequently Asked Questions
PART 210 is a regulatory concept used to improve submission quality, compliance consistency, and decision traceability.
PART 210 improves consistency in decisions, documentation, and authority communication.
Weak execution of PART 210 often leads to avoidable deficiencies, rework, and slower authority review cycles.
Related Terms
Related Use Cases
Cut NDA and sNDA prep time by 60% with AI-assisted drafting and automated readiness checks
Compress IND prep from 8-12 weeks to under 3 weeks with AI-assisted drafting and validation
Cut regulatory intelligence tracking from 10+ hours/week to automated, real-time alerts
Track GxP regulation changes and enforcement trends
Related Regulatory Intelligence
Related Actions
Sources & References
